These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38622730)

  • 1. Combating antimicrobial resistance through vaccines in children from low- and middle-income countries-a call for research.
    Gingaras C; Collins E
    J Trop Pediatr; 2024 Apr; 70(3):. PubMed ID: 38622730
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Social Media as a Tool to Reduce Antibiotic Usage: A Neglected Approach to Combat Antimicrobial Resistance in Low and Middle Income Countries.
    Acharya KP; Subedi D
    Front Public Health; 2020; 8():558576. PubMed ID: 33363074
    [No Abstract]   [Full Text] [Related]  

  • 3. Using 'smart regulation' to tackle antimicrobial resistance in low-income and middle-income countries.
    Porter G; Joshi J; Bhullar L; Kotwani A;
    BMJ Glob Health; 2020; 5(1):e001864. PubMed ID: 32133168
    [No Abstract]   [Full Text] [Related]  

  • 4. Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
    Mahadi AR
    Front Public Health; 2021; 9():770593. PubMed ID: 34976929
    [No Abstract]   [Full Text] [Related]  

  • 5. Developing bespoke antimicrobials to combat antimicrobial resistance in low- and middle-income countries: A critical appraisal of clinical utility in the elderly.
    MohanaSundaram A; Sathanantham ST; Sah R; Apostolopoulos V
    Maturitas; 2023 Apr; 170():74-75. PubMed ID: 36494242
    [No Abstract]   [Full Text] [Related]  

  • 6. Bidirectional effect of poverty and treatment-resistant diseases: The case of antimicrobial resistance in middle and low-income countries.
    Rahim F
    J Infect Public Health; 2024 Feb; 17(2):283-285. PubMed ID: 38141545
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial resistance data, frugal sequencing, and low-income countries in Africa.
    Aruhomukama D
    Lancet Infect Dis; 2022 Jul; 22(7):933-934. PubMed ID: 35594898
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries.
    de Kraker MEA
    PLoS Med; 2023 Jul; 20(7):e1004262. PubMed ID: 37436835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.
    Hsia Y; Sharland M; Jackson C; Wong ICK; Magrini N; Bielicki JA
    Lancet Infect Dis; 2019 Jan; 19(1):67-75. PubMed ID: 30522834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's wrong in the control of antimicrobial resistance in critically ill patients from low- and middle-income countries?
    Dondorp AM; Limmathurotsakul D; Ashley EA
    Intensive Care Med; 2018 Jan; 44(1):79-82. PubMed ID: 28409205
    [No Abstract]   [Full Text] [Related]  

  • 11. Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.
    Otaigbe II
    Front Public Health; 2024; 12():1292660. PubMed ID: 38532974
    [No Abstract]   [Full Text] [Related]  

  • 12. Global Antimicrobial Stewardship with a Focus on Low- and Middle-Income Countries.
    Pierce J; Apisarnthanarak A; Schellack N; Cornistein W; Maani AA; Adnan S; Stevens MP
    Int J Infect Dis; 2020 Jul; 96():621-629. PubMed ID: 32505875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines against antimicrobial resistance: a promising escape route for multidrug resistance.
    Talat A; Khan AU
    Pharm Pat Anal; 2021 Mar; 10(2):83-98. PubMed ID: 33829866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture.
    Iskandar K; Molinier L; Hallit S; Sartelli M; Hardcastle TC; Haque M; Lugova H; Dhingra S; Sharma P; Islam S; Mohammed I; Naina Mohamed I; Hanna PA; Hajj SE; Jamaluddin NAH; Salameh P; Roques C
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):63. PubMed ID: 33789754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines: An Armament in Combating Antimicrobial Resistance.
    Khan M
    J Coll Physicians Surg Pak; 2021 Mar; 31(3):249-252. PubMed ID: 33775009
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial resistance in countries with limited resources: unique challenges and limited alternatives.
    Sirinavin S; Dowell SF
    Semin Pediatr Infect Dis; 2004 Apr; 15(2):94-8. PubMed ID: 15185192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSAC Vanguard Series: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries.
    Berman D; Neale R
    J Antimicrob Chemother; 2021 Dec; 77(1):3-4. PubMed ID: 34791279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction to: Combating antimicrobial resistance through vaccines in children from low- and middle-income countries-a call for research.
    J Trop Pediatr; 2024 Apr; 70(3):. PubMed ID: 38773799
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial Resistance in Low- and Middle-income Countries.
    Chopra S; Rizvi M
    Clin Infect Dis; 2019 Sep; 69(7):1264-1265. PubMed ID: 30753365
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic Review of Antibiotic Resistance Rates Among Gram-Negative Bacteria in Children With Sepsis in Resource-Limited Countries.
    Le Doare K; Bielicki J; Heath PT; Sharland M
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):11-20. PubMed ID: 26407352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.